USFDA okays new antibiotic for highly drug-resistant tuberculosisPretomanid, a new chemical entity, was under development since 2002 by the TB Alliance.
States must invest in R&D to fund new drug discoveries: TB AllianceGeneric manufacturers are essential players in the fight to end TB so we do speak with generic manufacturers as part of our access strategy.
World TB Day: Over 25% TB patients in India are resistant to at least one anti-TB drug"High rates of treatment failure and deaths are associated with fluoroquinolone resistance in the Indian cohort of MDR-TB patients," stated...
J&J, Macleods in talks for licence deal of tuberculosis drugThe talks, which are in early stage, will allow Macleods to manufacture generic version of the drug, a move if goes through will improve ac...
Drug to treat MDRTB to be made available across the country: GovernmentUnion Health Minister J P Nadda, in a written reply, said that the states are being prepared to monitor the treatment of patients with Beda...
TB patients will not be denied treatment on basis of domicile: GovernmentIn December 2016, the father of an 18-year-old patient suffering from XDR TB took National Institute of Tuberculosis and Respiratory Diseas...
Hospital denies new TB drug to dying patient citing fear of drug resistanceLRS was responding to an affidavit asking whether the govt could provide the bedaquiline directly to the treating doctor instead of the pat...
Battle for access to tuberculosis medicine reaches HC"Patients need to be constantly monitored, which is why these centres are currently administering the drug only to residents of these six s...
Health Ministry dragged to court over curbs on TB drugsThe drugs –– Bedaquiline by US drugmaker J&J and Delamanid by Japanese drugmaker Otsuka Pharma –– are the only treatment option for patient...
4 of 6 drugs ineffective in 70% of deadly TB cases, Mumbai doctors sayFour of the six drugs given to patients with MDR-TB under the RNTCP could be ineffective in nearly 70% of patients, a study by Mumbai's Hin...
‘Miracle drug’ for resistant Tuberculosis to be rolled out for trial todayA ‘miracle drug’ to battle multi-drug resistant tuberculosis MDR-TB, and extensively-drug resistant TB (XDR-TB), will be rolled out on Mond...
Study reveals 57% of TB patients given wrong drugsHere's why drug-resistant tuberculosis (TB) breeds freely in Mumbai: Patients don't get appropriate medication.
Government drags feet on effective anti-TB drug BedaquilineGovernment officials say there are several reasons for this: bedaquiline is technically still in a trial phase and its cost in some high-in...
TB a national emergency: Health Minister Harsh VardhanVardhan said that an email repository will be built up for establishing connectivity between govt & all doctors in the country to help figh...
- World TB day: Need to raise public spend on clinical trials & find innovative ways to incentivise R&D
March 24 is World TB day. It commemorates the discovery of Tuberculosis (TB) bacillus in 1883 by Dr Robert Koch as the cause of tuberculosi...
- India should join global anti-TB plan: WB study
Countries like India and China, with high numbers of TB cases could gain more from the money they spend on diagnosis and treatment of the d...
- New drug-resistant TB strain poses threat to India
India has a major health challenge on its hands, figuring second on the list of countries with the largest concentration of people sufferin...